about
Glycogen synthase kinase-3 inhibition sensitizes pancreatic cancer cells to TRAIL-induced apoptosisAcquired activation of the Akt/cyclooxygenase-2/Mcl-1 pathway renders lung cancer cells resistant to apoptosisEarly growth response-1 is a regulator of DR5-induced apoptosis in colon cancer cells.Quercetin induced apoptosis in association with death receptors and fludarabine in cells isolated from chronic lymphocytic leukaemia patients.TRAIL and triptolide: an effective combination that induces apoptosis in pancreatic cancer cellsThe TRAIL of oncogenes to apoptosis.CD95 is part of a let-7/p53/miR-34 regulatory networkAPO010, a synthetic hexameric CD95 ligand, induces human glioma cell death in vitro and in vivo.Anoikis mediators in oral squamous cell carcinoma.Embelin-Induced Apoptosis of Human Prostate Cancer Cells Is Mediated through Modulation of Akt and β-Catenin Signaling.Delivery of sTRAIL variants by MSCs in combination with cytotoxic drug treatment leads to p53-independent enhanced antitumor effectsClusterin and chemoresistance.Molecules that modulate Apaf-1 activity.TRAIL receptor signaling and therapeutics.Inactivation of BRCA2 in human cancer cells identifies a subset of tumors with enhanced sensitivity towards death receptor-mediated apoptosis.Differential effects of alpha-particle radiation and x-irradiation on genes associated with apoptosis.Isolation and chemopreventive evaluation of novel naphthoquinone compounds from Alkanna tinctoria.Inhibition of the mitochondrial pyrimidine biosynthesis enzyme dihydroorotate dehydrogenase by doxorubicin and brequinar sensitizes cancer cells to TRAIL-induced apoptosis.Enhanced antitumor activity of the photosensitizer meso-Tetra(N-methyl-4-pyridyl) porphine tetra tosylate through encapsulation in antibody-targeted chitosan/alginate nanoparticlesType I IFNs signaling and apoptosis resistance in glioblastoma cells.Inhibition of nuclear factor-kappa B differentially affects thyroid cancer cell growth, apoptosis, and invasion.Moutan Cortex Radicis inhibits inflammatory changes of gene expression in lipopolysaccharide-stimulated gingival fibroblasts.
P2860
Q28729017-D2C1F4DE-B550-4AF8-9463-4FD5BE3FC30AQ33714703-A7498621-C798-4835-AAA1-8789D65F7229Q33723716-C18CE3C6-8778-4EF4-B0B9-E08FD12D6775Q34122737-2D24463E-2B24-41E9-A91C-5F012C141720Q34324431-F973273B-51F7-4866-ABC1-89ADD451DAF6Q34354511-D0072E92-2647-4175-A7A8-AB8021DFC750Q34482626-8D77109E-E71A-41EE-933D-7E09F2914A4FQ34722539-5F8E4A91-D421-48AC-AF20-05BC46B8E443Q34770470-74093D29-3078-4136-9F80-D9B01FD92852Q35739596-CB778542-20D6-4C57-9CBD-249D9BA5BC08Q37073589-E683DAB2-204C-458C-8A3E-BF203646D8DAQ37625188-8B676707-930C-40F8-B7FC-8239E25C460FQ37680800-78DF2ADC-EDB8-496C-82FB-C005C0A78EF9Q37785559-B0014768-BDF9-4C7C-BE05-0088B052F699Q38796779-1FAEB376-573E-4CA5-B7EB-1629B2981ADBQ38802078-BC3190E3-0EC9-45CA-9360-20B9AF84ADDDQ39097135-C168DCDE-60A5-4B64-9018-42DC8D54597FQ39098785-F4234361-10D1-4668-86CE-BAFC4DE96D4FQ39209045-91673E4E-6929-4D78-AD67-6B8AAF642B34Q39486541-E30133CF-BD0D-4994-A711-839F923ED0CCQ39701467-80ACDEF9-F9CA-40B6-B08F-D3DB64986ADBQ45002880-6FBAD424-DDC7-472B-86E5-D8812F7B79D9
P2860
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on December 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Death receptors as targets for anti-cancer therapy.
@en
Death receptors as targets for anti-cancer therapy.
@nl
type
label
Death receptors as targets for anti-cancer therapy.
@en
Death receptors as targets for anti-cancer therapy.
@nl
prefLabel
Death receptors as targets for anti-cancer therapy.
@en
Death receptors as targets for anti-cancer therapy.
@nl
P2093
P2860
P921
P1476
Death receptors as targets for anti-cancer therapy.
@en
P2093
Henning Walczak
Kerstin Papenfuss
Stefanie M Cordier
P2860
P304
P356
10.1111/J.1582-4934.2008.00514.X
P577
2008-12-01T00:00:00Z